Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.09M | 165.92M | 216.89M | 243.57M | 269.91M |
| Total Receivables | 31.14M | 33.42M | 25.50M | 22.54M | 27.88M |
| Inventory | 41.23M | 40.46M | 40.50M | 45.33M | 46.67M |
| Prepaid Expenses | 12.71M | 11.94M | 13.37M | 14.43M | 15.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 490.00K | -- | -- | -- | -- |
| Total Current Assets | 155.66M | 251.74M | 296.25M | 325.87M | 359.76M |
|
|
|||||
| Total Current Assets | 155.66M | 251.74M | 296.25M | 325.87M | 359.76M |
| Net Property, Plant & Equipment | 142.41M | 146.93M | 190.74M | 158.62M | 162.73M |
| Long-term Investments | 129.43M | 129.43M | 129.43M | 129.43M | 129.43M |
| Goodwill | 129.43M | 129.43M | 129.43M | 129.43M | 129.43M |
| Total Other Intangibles | 138.38M | 144.89M | 151.54M | 185.88M | 193.07M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.87M | 40.24M | 2.62M | 49.40M | 51.98M |
| Total Assets | 603.75M | 713.22M | 770.58M | 849.19M | 896.97M |
|
|
|||||
| Total Accounts Payable | 7.13M | 8.54M | 2.91M | 8.00M | 11.53M |
| Total Accrued Expenses | 13.21M | 14.64M | 22.60M | 31.12M | 23.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.65M | 15.45M | 14.20M | 14.50M | 14.24M |
| Total Finance Division Other Current Liabilities | 7.43M | 4.00M | 5.21M | 7.96M | 19.94M |
| Total Other Current Liabilities | 7.43M | 4.00M | 5.21M | 7.96M | 19.94M |
| Total Current Liabilities | 38.42M | 42.62M | 44.92M | 61.57M | 69.68M |
|
|
|||||
| Total Current Liabilities | 38.42M | 42.62M | 44.92M | 61.57M | 69.68M |
| Long-Term Debt | 145.98M | 235.57M | 286.33M | 287.38M | 288.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 61.47M | 64.02M | 64.18M | 66.06M | 68.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.29M | 1.93M | 2.44M | 2.32M | 2.46M |
| Total Liabilities | 248.16M | 344.13M | 397.87M | 417.33M | 428.98M |
|
|
|||||
| Common Stock & APIC | 210.19M | 204.71M | 201.74M | 199.07M | 193.93M |
| Retained Earnings | -6.03M | 6.39M | 10.12M | 45.80M | 71.36M |
| Treasury Stock & Other | 459.00K | 466.00K | 524.00K | 579.00K | 574.00K |
| Total Common Equity | 204.62M | 211.56M | 212.38M | 245.44M | 265.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 204.62M | 211.56M | 212.38M | 245.44M | 265.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 150.97M | 157.52M | 160.33M | 186.42M | 202.12M |
| Total Equity | 355.59M | 369.08M | 372.71M | 431.86M | 467.98M |
|
|
|||||